AMENDMENT NO. 2 TO LOAN AGREEMENTLoan Agreement • September 22nd, 2009 • Pharmacyclics Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 2 to LOAN AGREEMENT entered into as of June 17, 2009 (this "Amendment") by and between Pharmacyclics, Inc., a Delaware corporation having a principal place of business at 995 E. Arques Avenue, Sunnyvale, CA 94085-4521 (the "Company"), Robert W. Duggan & Associates and Blazon Corporation Profit Sharing Plan (the "Lender");
COLLABORATION AGREEMENT BY AND BETWEEN PHARMACYCLICS, INC., AND LES LABORATOIRES SERVIER AND INSTITUT DE RECHERCHES INTERNATIONALES SERVIER April 16, 2009Collaboration Agreement • September 22nd, 2009 • Pharmacyclics Inc • Pharmaceutical preparations
THIS COLLABORATION AGREEMENT (the "Agreement") is made effective as of April 16, 2009 (the "Effective Date") by and between Pharmacyclics, Inc., a corporation organized under the laws of the State of Delaware, having offices at 995 East Arques Avenue, Sunnyvale, California 94085, United States of America, ("Pharmacyclics"),and Les Laboratoires Servier, a company organized under the laws of France, having offices at 22 rue Garnier, 92200 Neuilly sur Seine Cedex, France ("Servier") and Institut de Recherches Internationales Servier, a company organized under the laws of France, having offices at 6, Place des Pléiades, 92415 Courbevoie. Pharmacyclics and Servier are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
